Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1147422-92-1 | MDL No. : | MFCD13180578 |
Formula : | C7H12N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZSJNNIPCNKKLHD-UHFFFAOYSA-N |
M.W : | 140.18 | Pubchem ID : | 21692403 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.86 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 44.91 |
TPSA : | 41.13 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.75 cm/s |
Log Po/w (iLOGP) : | 1.37 |
Log Po/w (XLOGP3) : | -0.84 |
Log Po/w (WLOGP) : | -1.28 |
Log Po/w (MLOGP) : | 0.72 |
Log Po/w (SILICOS-IT) : | 1.09 |
Consensus Log Po/w : | 0.21 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.18 |
Solubility : | 92.6 mg/ml ; 0.661 mol/l |
Class : | Very soluble |
Log S (Ali) : | 0.46 |
Solubility : | 401.0 mg/ml ; 2.86 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -1.77 |
Solubility : | 2.36 mg/ml ; 0.0169 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.57 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1187173-43-8 ]
2,7-Diazaspiro[4.5]decan-1-one hydrochloride
Similarity: 0.89
[ 832710-65-3 ]
2,8-Diazaspiro[4.5]decan-1-one hydrochloride
Similarity: 0.89
[ 1203796-97-7 ]
2,7-Diazaspiro[4.4]nonan-1-one
Similarity: 0.89
[ 16994-00-6 ]
3-Azabicyclo[3.2.1]octan-2-one
Similarity: 0.88
[ 1187173-43-8 ]
2,7-Diazaspiro[4.5]decan-1-one hydrochloride
Similarity: 0.89
[ 832710-65-3 ]
2,8-Diazaspiro[4.5]decan-1-one hydrochloride
Similarity: 0.89
[ 1203796-97-7 ]
2,7-Diazaspiro[4.4]nonan-1-one
Similarity: 0.89
[ 16994-00-6 ]
3-Azabicyclo[3.2.1]octan-2-one
Similarity: 0.88
[ 1124199-15-0 ]
(R)-N-Methylpiperidine-3-carboxamide
Similarity: 0.88
[ 1235440-17-1 ]
1,7-Diazaspiro[3.5]nonan-2-one
Similarity: 0.81
[ 1956325-48-6 ]
(3-Aminoazetidin-1-yl)(cyclopropyl)methanone hydrochloride
Similarity: 0.73
[ 1588440-97-4 ]
2,6-Diazaspiro[3.4]octan-7-one oxalate
Similarity: 0.71
[ 1334536-88-7 ]
7-Benzyl-1-oxo-2,7-diazaspiro[3.5]nonane
Similarity: 0.69
[ 1187173-43-8 ]
2,7-Diazaspiro[4.5]decan-1-one hydrochloride
Similarity: 0.89
[ 832710-65-3 ]
2,8-Diazaspiro[4.5]decan-1-one hydrochloride
Similarity: 0.89
[ 1124199-15-0 ]
(R)-N-Methylpiperidine-3-carboxamide
Similarity: 0.88
[ 1187173-43-8 ]
2,7-Diazaspiro[4.5]decan-1-one hydrochloride
Similarity: 0.89
[ 832710-65-3 ]
2,8-Diazaspiro[4.5]decan-1-one hydrochloride
Similarity: 0.89
[ 1203796-97-7 ]
2,7-Diazaspiro[4.4]nonan-1-one
Similarity: 0.89
[ 561314-57-6 ]
2,8-Diazaspiro[4.5]decan-3-one
Similarity: 0.88
[ 2696-03-9 ]
2,8-Diazaspiro[4.5]decane-1,3-dione hydrochloride
Similarity: 0.86